alpha-aminopyridine has been researched along with Diabetic Nephropathies in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Karpe, PA; Kumar, S; Lodea, S; Tikoo, K | 1 |
| Amaro, M; Birnbaum, MJ; Bollinger, E; Boucher, GG; Calabrese, MF; Cameron, KO; Cialdea, K; Cokorinos, E; Coskran, TM; DaSilva-Jardine, P; Edmonds, DJ; Gandhok, H; Genung, NE; Jatkar, A; Kalgutkar, AS; Kreeger, JM; Kurumbail, RG; Maciejewski, BS; Miller, RA; Monetti, M; Opsahl, AC; Rajamohan, F; Reyes, A; Rolph, T; Salatto, CT; Shavnya, A; Tess, DA; Ward, J | 1 |
2 other study(ies) available for alpha-aminopyridine and Diabetic Nephropathies
| Article | Year |
|---|---|
Calorie restriction mimicking effects of roflumilast prevents diabetic nephropathy.
Topics: Adenylate Kinase; Aminopyridines; Animals; Benzamides; Blood Glucose; Blood Urea Nitrogen; Caloric Restriction; Creatinine; Cyclopropanes; Diabetic Nephropathies; In Situ Nick-End Labeling; Male; Rats; Rats, Sprague-Dawley; Sirtuin 1 | 2014 |
Selective Activation of AMPK
Topics: Aminopyridines; AMP-Activated Protein Kinases; Animals; Cell Size; Diabetic Nephropathies; Enzyme Activation; Enzyme Activators; Fibrosis; Humans; Indoles; Isoenzymes; Kidney; Kidney Function Tests; Macaca fascicularis; Mice, Inbred C57BL; Oxidative Stress; Phosphorylation; Proteinuria; Rats; Species Specificity | 2017 |